Septerna, Inc. (SEPN)
25.41
+0.97
(+3.97%)
USD |
NASDAQ |
Feb 06, 16:00
25.43
+0.02
(+0.08%)
After-Hours: 20:00
Septerna EPS Diluted (Quarterly) : 0.1792 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.875 |
| Innoviva, Inc. | 1.082 |
| Oramed Pharmaceuticals, Inc. | 1.131 |
| Theravance Biopharma, Inc. | 0.0696 |
| Liquidia Corp. | -0.0409 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 8.173M |
| Revenue (Quarterly) | 21.50M |
| Total Expenses (Quarterly) | 13.32M |
| Enterprise Value | 687.48M |
| Gross Profit Margin (Quarterly) | 98.14% |
| Profit Margin (Quarterly) | 38.02% |
| Earnings Yield | -5.94% |
| Normalized Earnings Yield | -5.943 |